Revenue segments as reported by the company.

Cannabis revenue

Distribution revenue

Beverage alcohol revenue

Wellness revenue

Adult-use

Canada - Medical

International - Medical

Bulk

Hemp

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Impairment of Assets

Litigation settlement

Transaction costs

Change in fair value of contingent consideration

Restructuring costs

Other than temporary change in fair value of convertible notes receivable

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Tilray Brands

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consists of hemp seed, hemp foods, and broad spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Earnings data Q1 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Tilray Brands reports record revenue and optimistic outlook for 2025

Tilray Brands achieved remarkable financial performance in Q4 2024, driven by strategic acquisitions and a focus on innovation. Despite challenges like price compression, the company remains optimistic about future growth opportunities. Tilray's commitment to quality products and innovation positions it well for continued success in the market.

Tilray Brands reports record Q1 revenue growth and global expansion

Tilray Brands delivered a robust performance in Q1 2025, showcasing strong revenue growth, margin improvement, and strategic expansion across its diversified product portfolio.
While facing challenges in a competitive landscape and evolving regulatory environment, Tilray's financial strength, international growth initiatives, and focus on innovation position it well for future success.
By capitalizing on opportunities in wellness products, expanding into new beverage categories, and leveraging strategic partnerships, Tilray is poised for continued growth and market leadership.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. The Cannabis Business segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution Business segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage Alcohol Business segment refers to the production, marketing, and sale of beverages. The Wellness Business segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

The owners of TLRY stock might be pleasantly surprised to learn that the company is holding up fairly well.
The post Tilray Stock Is Likely to Keep Recovering appeared first on InvestorPlace.

Tilray Stock Is Likely to Keep Recovering

While risk remains in the cannabis space, TLRY stock could soon trigger a massive wave of short covering if it maintains its momentum. 
The post Why Tilray May Be a Ticking Time Bomb appeared first on InvestorPlace.

Why Tilray May Be a Ticking Time Bomb

They can blame a high-profile peer in their sector.

Why Tilray and OrganiGram Holdings Got Slammed on Friday

Cannabis producer Tilray Inc. TLRY, +5.36% said late Tuesday it planned to shut down High Park Gardens, a greenhouse it owns in Leamington, Ontario, and part of a C$70 million ($50.8 million) acquisition of Natura Naturals Holdings Inc.

Tilray to close Ontario pot grow it acquired as part of a $51 million deal last year

Aurora Cannabis

Aphria

Canopy Growth

Cronos Group

Curaleaf Holdings, Inc.

HEXO Corp

Marijuana stocks are already getting buying interest ahead of the major event

7 Marijuana Stocks to Watch as the Presidential Election Approaches

Tilray (TLRY) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.

Tilray (TLRY) Catches Eye: Stock Jumps 6.3%

COVID-19 could be what seals the fates of many pot stocks this year.

Tilray's CEO Expects at Least a Dozen Cannabis Bankruptcies in 2020 -- Is He Right?

Amplify Alternative Harvest ETF

Cannabis company stocks are skyrocketing as investors are high on new hopes that marijuana might help ward off the deadly coronavirus.

Cannabis stocks soar on hopes pot wards off coronavirus

Bed Bath & Beyond

SeaWorld Entertainment

Rotation into small-cap stocks this week is shining a light on beaten-down equities. Here are three of the best-looking trade ideas.

3 Small-Cap Stocks to Trade as They Rise From the Ashes

Compared to its innovative peers like Cronos and Canopy Growth, Tilray is destined to fail. That's why investors should avoid TLRY stock now.

Tilray Stock Is a Loser in the Cannabis World

Canadian cannabis company Tilray Inc. (NASDAQ: TLRY) has turned around in recent weeks.

How Safe, Legal Pot Boosted Tilray Stock in COVID-19 Era

Before you decide to buy or sell Tilray stock and move on to another cannabis play, at least take the time to consider three numbers from its quarterly report. I won’t say which way I’m leaning toward Tilray until the end -- the last time I wrote about TLRY in November, I cautioned investors to wait for a catalyst before buying -- but I can say that Tilray’s business isn’t nearly as bad as the headlines suggest.

3 Numbers to Study Before Jumping on the Tilray Bandwagon

Canada-based cannabis grower Tilray Inc. (NASDAQ: TLRY) reported first-quarter 2020 earnings results on May 11.

Tilray Stock Needs EU Markets and Cost Savings to Recover

The cannabis stock enthusiasm on Wall Street went up in smoke. But doesn't mean that TLRY stock is baked.

Tilray Stock Can Still Target $11 Per Share and Beyond

Tilray Inc (NASDAQ: TLRY) reported stable first-quarter results Monday, beating expectations across key metrics.

Tilray Investors Overreacted To A Good Q1 Print, Says Cantor Fitzgerald

The cannabis company managed to narrow its net loss on a quarter-over-quarter basis, but that loss was still considerable.

Tilray Drops Nearly 6% in After-Hours Trading Following Q1 Report

Cannabis stocks in general stumbled in the latter half of last year. Wall Street expects profits, and none of these companies is anywhere near profitability.

Cannabis Stocks See Rising Tide in Short Interest

The Canadian cannabis company expects an improving bottom line in future quarters.

Why Tilray's Revenue Soared and Its Loss Widened in Q1

Tilray Inc (TLRY) CEO Brendan Kennedy on Q1 2020 Results - Earnings Call Transcript

Tilray Inc (TLRY) delivered earnings and revenue surprises of -11.36% and 4.85%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Tilray Inc (TLRY) Reports Q1 Loss, Tops Revenue Estimates

NVIDIA

Penn Entertainment

Datadog

Tilray and Datadog are set to report earnings, while Nvidia and Penn Gaming continue to trade well. So, let's look at a few top stock trades.

4 Top Stock Trades for Tuesday: NVDA, TLRY, DDOG, PENN

Tilray reports after the close today as analysts warn of cascading effects on the industry from coronavirus shutdowns.
The post Tilray Earnings Due As Pot Industry Faces This 'Vicious Cycle' appeared first on Investor's Business Daily.

Tilray Earnings Due As Pot Industry Faces This 'Vicious Cycle'

The stress of quarantine lockdown may be enough to drive a person to drink or drugs.

Why to Keep an Eye on Tilray Stock

The marijuana stock rebounded slightly from the prior month's drubbing.

Why Tilray Stock Gained 17% in April

You don't have to make a social statement in selling TLRY stock. The company's fiscal performance is more than enough reason to sell shares.

News for Tilray Brands Stock (TLRY)